Changes

'''Genentech, Inc.''' is a [[pharmaceutical]] company and one of the world's most financially successful and [[biotechnology]] corporations. Genentechhas three drugs that are billion-dollar sellers: Rituxan, for non-Hodgkin's lymphoma; [[Avastin]], which is based in San Franciscofor colorectal, Californianon-small cell lung cancers, Uand treats macular degeneration; and [[Herceptin]] for breast cancer.SIt also manufactures the lung cancer drug Tarceva. Major customers for its drugs are [[AmerisourceBergen]], is 56% owned by [[Cardinal Health]], and [[McKesson]]. The Swiss drug company [[Roche]], which previously owned a majority of stock in the San Francisco based firm, took full ownership in 2009.<ref name="Hoovers">[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech Profile], ''Hoovers'', accessed December 2009</ref> According to its website, the company is "considered the founder of the biotechnology industry." <ref>[http://www.gene.com/gene/about/index.html About Us: Leading the Biotechnology Industry], Genentech, accessed July 2007.</ref>

In the fiscal year ending in December of 2008, Genentech had sales of 13.4 billion dollars and had 11,174 employees. <ref>[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech], Hoovers, accessed December 2009</ref> ==LobbyingTies to the American Legislative Exchange Council==According to [[Lisa Graves]] '''Genentech''' has been a corporate funder of the [[Center for Media and DemocracyAmerican Legislative Exchange Council]] a search of (ALEC)<ref>American Legislative Exchange Council, [http://legacy.library.ucsf.edu/tid/xac25b00/pdf Keeping the Lobby Disclosure Act database Promise: Making Health Care Accessible and Affordable for "Genentech" spending All Americans], January 1993, archived in 2009 reveals that Legacy Tobacco Documents Library, accessed July 2011</ref><ref>Clearinghouse on Environmental Advocacy and Research, project of the company spent over Environmental Working Group, [http://web.archive.org/web/200012021600/http://wyl.ewg.org/FoxProCGI.acgi$3.7 million in lobbying Congress run_module?data_code=CLEAR&extra_code=group_code=ORG197&the_type=Group& Information on health care issues in the first three quarters on the yearAmerican Legislative Exchange Council], archived organizational profile, including over $archived by Wayback Machine December 2, 2000, accessed August 19, 2011</ref>.1 million itself and the remainder on lobbyists such as the See [[American Continental GroupALEC Corporations]]for more. {{about_ALEC}}==Dollars for Docs==Genentech has paid $388 million to 1,888 doctors, according to ProPublica's Dollars for Docs<ref>Lisa Graves[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Has Your Doctor Received Drug Company Money? - Genentech], Center Dollars for Media and DemocracyDocs, accessed April 2016</ref>, including to industry consultant Dr. Peter Bach.[[https://www.sourcewatch.org/index.php/Dr._Peter_Bach#cite_note-4]] ==Animal testing== Genentech does [[animal testing]]. ===Facility information, "Biotechprogress reports & USDA-APHIS reports===For links to copies of a facility's Ghostwriting Animates Congressional Speeches on [[U.S. Department of Agriculture]] (USDA)-Animal Plant Health ReformInspection (APHIS) reports, November 15other information and links, 2009see also [http://www.all-creatures.<org/saen/ref> res-fr.html Stop Animal Experimentation NOW!: Facility Reports and Information]. Genentech's lobbying made the news after its talking points showed up This site contains listings for all 50 states, links to biomedical research facilities in the statements that several Members state and PDF copies of Congress submitted to the Congressional Recordgovernment documents where facilities must report their animal usage. (Search: Genentech, Inc., San Francisco, the official journal California.)  ===USDA AWA reports===As of congressional proceedingsMay 26, during the 2009 debate over health care reforms.<ref>Robert Pear, New York Timesthe USDA began posting all inspection reports for animal breeders, "In Housedealers, Many Spoke with One Voice: Lobbyistsexhibitors," November 15, 2009handlers, research facilities and animal carriers by state. See also [http://www.nytimesaphis.comusda.gov/2009animal_welfare/11/15/us/politics/15healthinspection_list.shtml USDA Animal Welfare Inspection Reports].html?pagewanted ==Clinical trials==  ===Toxic drug trials on foster children===2&_rSee also [[foster child drug trials]]. =1&adxnnl=1Selected staff &refboard=politics&adxnnlx=1258294232 * [[Arthur Levinson]] - Chairman * [[Ian Clark]] - CEO * [[Steve Krognes]] - CFO <ref>[http://www.hoovers.com/genentech/--ID__10628--7WmWloVRzvQfa4/As1ohkQfree-co-factsheet.xhtml Company Description: Genentech]., Hoovers, accessed March 2010</ref> * [[Laura A. Leber]]* [[Amo Houghton]]

==Political Contributions=Former staff===Genentech gave almost $400,000 to candidates in the 2008 election cycle through its * [[political action committeeJ. Richard Munro]].- CEO <ref>[http://www.campaignmoneypointsoflight.com/politicalorg/committeesabout/genentech-inc-political-action-committee-genenpacdirectors.asp?cycle=08cfm Board of Directors], "CampaignMoney.com[[Points of Light Foundation]]," accessed on November 15, 2009.July 2007</ref> This is almost twice as much as in 2006, when it donated $201,500 to federal candidates in the 2006 election through its * [[political action committeeWilliam D. Young]] - 38% to [[Democrats]] and 57% to [[Republican Party (USA)|Republicans]].COO <ref>[http://www.opensecretsbiogenidec.orgcom/pacssite/lookup2030.asp?strid=C00199257&cycle=2006 2006 PAC Summary Datahtml Board of Directors], ''Open Secrets''[[Biogen Idec]], accessed December July 2007.</ref>

==Key executives and 2006 pay=Board===*[[Arthur DHerbert W. LevinsonBoyer]], PhD, Vice-Chairman and Chief Executive Officer, $17,124,025 (also exercised $66,268,100 in options)<ref>of the Board - [[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=938049 Arthur D LevinsonAllergan]], ''Forbes'', accessed December 2007Inc.</ref>*[[Susan DWilliam M. Desmond-HellmannBurns]]* [[Erich Hunziker]], Divisional President, $7,820,142 (also exercised $33,465,041 in options)<ref>* [[http://wwwJonathan K.forbesC.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=935873 Susan D Desmond-HellmannKnowles]], ''Forbes'', accessed December 2007.</ref>PhD*[[David AArthur D. EbersmanLevinson]], Chief Financial Officer, $4,030,747<ref>PhD - Board - [[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=880695 David A EbersmanApple Computer]], ''Forbes'', accessed December 2007Inc.</ref>*[[Stephen GDebra L. JuelsgaardReed]], Executive Vice President, $4,896,340 (also exercised $24,980,534 in options)<ref>- Board - [[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=899284 Stephen G JuelsgaardHalliburton Company]], ''Forbes'', accessed December 2007.</ref>*[[Richard HCharles A. SchellerSanders]], Divisional Executive Vice President, $4,992,779 (also exercised $10,880,395 in options)MD <ref>[http://www.forbesgene.com/financegene/mktguideappsabout/personinfomanagement/FromPersonIdPersonTearsheetboard_of_directors.jhtml?passedPersonId=929696 Richard H Schellerhtml Board of Directors], ''Forbes''Genentech, accessed December July 2007</ref>

==Selected staffExecutive compensation (2007)==*[[Laura A. Leber]]*[[J. Richard Munro]] - Retired Chairman of the Board <ref>Points of Light Foundation, [http://www.pointsoflight.org/about/directors.cfm Board of Directors], accessed July 2007</ref>*[[William D. Young]] - Former Chief Operating Officer <ref>BiogenIDEC[http://www.biogenidec.com/site/030.html Board of Directors], , accessed July 2007</ref>*[[Amo Houghton]]

* [[Arthur D. Levinson]], Chairman, CEO - $17,124,025 (also exercised $66,268,100 in options)<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId==Products==938049 Arthur D Levinson], ''Forbes'', accessed December 2007.</ref>The company has three drugs that are billion* [[Susan D. Desmond-dollar sellers: RituxanHellmann]], for nonDivisional President -Hodgkin's lymphoma; Avastin$7, for colorectal and non-small cell lung cancers820, which 142 (also treats macular degeneration; and Herceptin for breast cancerexercised $33,465,041 in options)<ref>[http://www. It also has the lung cancer drug Tarcevaforbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=935873 Susan D Desmond-Hellmann], ''Forbes'', accessed December 2007. Big customers for its drugs are </ref>* [[AmerisourceBergenDavid A. Ebersman]]- CEO - $4, 030,747<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=880695 David A Ebersman], ''Forbes'', accessed December 2007.</ref>* [Cardinal Health[Stephen G. Juelsgaard]]- Executive VP - $4,896,340 (also exercised $24,980, and 534 in options)<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=899284 Stephen G Juelsgaard], ''Forbes'', accessed December 2007.</ref>* [[McKessonRichard H. Scheller]], Divisional Executive VP - $4,992,779 (also exercised $10,880,395 in options)<ref>[http://www. forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=929696 Richard H Scheller], ''Forbes'', accessed December 2007</ref>

In 2006, Genentech sales were US$9.3 billion with profits of US$2.1 billion.<ref name="Hoovers" />=Political Contributions==

Genentech gave almost $400,000 to candidates in the 2008 election cycle through its [[political action committee]] (PAC).<ref>[http://www.campaignmoney.com/political/committees/genentech-inc-political-action-committee-genenpac.asp?cycle==Animal testing==08 Genentech, Inc. Political Action Committee], CampaignMoney.com, accessed March 2010</ref>

Genentech does This is almost twice as much as in 2006, when it donated $201,500 to federal candidates. - 38% to [[animal testingDemocrats]]and 57% to [[Republican Party (USA)|Republicans]].<ref>[http://www.opensecrets.org/pacs/lookup2. asp?strid=C00199257&cycle==Animals by species2006 2006 PAC Summary Data], ''Open Secrets'', numbers & location===accessed December 2007.</ref>

For links According to copies [[Lisa Graves]] of this facility's the [[U.S. Department of AgricultureCenter for Media and Democracy]] reports indicating species, number a search of animals used and other information visit the 2009 ''Lobby Disclosure Act'' database for Genentech, revealed that the company spent over $3.7 million [[lobbying]] [[Congress]] on [[http://wwwhealth care]] issues in the first three quarters on the year.all-creatures The company spent over $2.org/saen/res1 million dollars on in-frhouse lobbyists with the remainder going to outside firms such as the [[American Continental Group]].html Stop Animal Experimentation Now Facility Reports and Information<ref>[[Lisa Graves]], U.S. Department of Agriculture-Animal Plant ''Biotech's Ghostwriting Animates Congressional Speeches on Health Inspection reports. This Web site lists each of the 50 states; each stateReform''s name links to biomedical research facilities in that state, [[Center for Media and to PDF copies of government documents where the facilities must report their animal usageDemocracy]], November 15, 2009.</ref>

==From Genetech's lobbying made the news after its website=="Considered talking points showed up in the founder statements submitted by several members of Congress to the biotechnology industry, Genentech has been delivering on Congressional Record (the promise official journal of biotechnology for more than 30 yearscongressional proceedings), using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needsduring the 2009 health care reform debate." <ref>Robert Pear [http://www.genenytimes.com/gene2009/about11/index15/us/politics/15health.html Corporate Overview?pagewanted=2&_r=1&adxnnl=1&ref=politics&adxnnlx=1258294232-7WmWloVRzvQfa4/As1ohkQ In House, Many Spoke with One Voice: Lobbyists], Genentech[[New York Times]], accessed July 27, 2007.November 2009</ref>

== Board of DirectorsContact==*[[Herbert W. Boyer]], Ph.D., Also Vice-Chairman of the Board of Directors of [[Allergan]], Inc.*[[William M. Burns]]*[[Erich Hunziker]]*[[Jonathan K.C. Knowles]], Ph.D.*[[Arthur D. Levinson]], Ph.D., Also member of the Board of Directors of [[Apple Computer]], Inc.*[[Debra L. Reed]], Also on the Board of Directors of [[Halliburton Company]]*[[Charles A. Sanders]], M.D.<ref>Genentech, Inc. [http://www.gene.com/gene/about/management/board_of_directors.html Board of Directors], accessed July 2007</ref>

Webaddress: http://www.gene.com

* [[AIDS industry]]* [[Animal testing]]*[[Biotechnology]]* [[Foster child drug trials]]* [[HIV/AIDS]]*[[Pharmaceutical industry]]*[[Animal testingRoche]]*[[Medical Industrial ComplexStephen Evans-Freke]]- former lead investment banker*[[War on Cancer]]*[[Stacy Feld]]*[[Ralph Snyderman]]*[[Sir John Bell]]*[[Pascal Soriot]] - former CEO

[[categoryCategory:Global corporations]] [[Category:HealthPharmaceutical industry]][[Category:Pharmaceutical industryInternational]][[categoryCategory:United StatesAnimal testing]] [[Category: Animal testingBiotechnology]] [[Category: Cancer]][[Category:AIDS]][[Category:Human rights abuses]][[Category:ALEC Exposed]]